1996
DOI: 10.1590/s0102-695x1996000100003
|View full text |Cite
|
Sign up to set email alerts
|

Vigilância de fitoterápicos - I: o caso da arnica

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0
1

Year Published

2005
2005
2007
2007

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
1
0
1
Order By: Relevance
“…The need to extend pharmacovigilance to include products of plant origin also, has been under discussion for almost 10 years now, in that these may pose a potential health risk (Marques, 1996); however, this practice is as yet incipient in Brazil. In spite of this, there are a great many cases of toxic effects and of adverse reactions triggered by medicinal plants and phytomedicines (Veiga Junior et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…The need to extend pharmacovigilance to include products of plant origin also, has been under discussion for almost 10 years now, in that these may pose a potential health risk (Marques, 1996); however, this practice is as yet incipient in Brazil. In spite of this, there are a great many cases of toxic effects and of adverse reactions triggered by medicinal plants and phytomedicines (Veiga Junior et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…O aumento da demanda, associado à falta de fiscalização efetiva que garanta desde a exploração racional dos recursos naturais empregados como matéria-prima, até a dispensação do produto acabado, contribuem para a disponibilidade e acesso a produtos muitas vezes sem condições adequadas ao uso, sem garantia da qualidade, segurança e eficiência, fundamentais para a recuperação ou preservação da saúde do consumidor (Bent e Ko, 2004;Calixto, 2000;Chan, 2003;De Smet, 2004;Elvin-Lewis, 2001;Giveon et al, 2004;Rates, 2001;Marques, 1996).…”
Section: Introductionunclassified